A Single Blind, Randomized, parallel group study to compare efficacy and safety of Unani formulation Qurs-e-Mafasil with Paracetamol in patients with Tahajjur al-Mafasil(Osteoarthritis)

Central Council for Research in Unani Medicine CCRUM New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年2月21日

研究概览

暂无简介。

•1. Subjects fulfilling ACR clinical criteria for knee OA; andor
•2. Subjects having grade II and III Osteoarthritisin knee radiography as perKellegrenLawrence criteria
•3. Subjects presenting with/ without the following signs and symptoms:
•Early morning stiffness
•Reduced mobility

•1. Subjects having Rheumatoid arthritis, Systemic joint disease or any other type of arthritis
•2. Obese Subjects having BMI >30
•3. Subjects with uncontrolled Hypertension, Diabetes Mellitus, Tuberculosis, Malignancy, Epilepsy and any other disease requiring long-term treatment
•4. Known cases of Renal/ hepatic impairment
•5. Patient receiving Intra-articular treatment (e.g., Corticosteroid or Hyaluronic acid) or treatment with medicine for O.A. in previous 3 months (e.g., Glucosamine sulphate, Chondroitin sulphate, Diacerine piascledine)
•6. Subjects undergone Arthroscopy or any Knee surgery during last 6 months
•7. Pregnancy & lactation

发起方

Central Council for Research in Unani Medicine CCRUM New Delhi